Saffron extract,
does it really help with Improved drug-induced erectile dysfunction in men taking fluoxetine?
research showsSaffron extract for fluoxetine-induced erectile dysfunction in men is rated C. In a four-week double-blind placebo-controlled trial that randomized 36 men and was completed by 30, saffron 15 mg twice daily improved IIEF total score, erectile function, and intercourse satisfaction; normal erectile function was reached by 60% versus 7%. Consistent positive findings across related outcomes in a randomized, double-blind, placebo-controlled design should not be treated as null or poor-quality evidence. The result has not been independently replicated in the same male indication, however, the sample was small, follow-up lasted only four weeks, and orgasmic function, sexual desire, and overall satisfaction did not differ significantly. A 2022 systematic review also described saffron as a possible positive signal while emphasizing mixed results and the need for larger trials. Under rule ①, these limitations cap the verdict at a low C with 42 points. Supplement quality variation, gastrointestinal effects at high doses, possible bleeding risk, and pregnancy precautions remain separate safety issues.
ads claimMarketing can turn one small trial into claims of a natural Viagra, a solution to all SSRI sexual adverse effects, or restored desire and orgasm. The actual positive result is limited to four-week erectile function and intercourse satisfaction in selected men who continued fluoxetine; desire, orgasm, overall satisfaction, and long-term benefit remain unconfirmed.
Useful facts when choosing a product
- The pivotal trial used saffron 15 mg twice daily, totaling 30 mg daily for four weeks. Commercial extracts are not guaranteed to match its extraction ratio or crocin and safranal content.
- Fluoxetine is a prescription drug, so sexual adverse effects should not prompt unsupervised dose reduction or discontinuation; causes and alternatives should be discussed with the prescriber.
- Adverse-event frequency was similar to placebo in the short trial, but higher-dose saffron may cause nausea, abdominal discomfort, or dizziness and could increase bleeding risk, requiring caution with anticoagulants or antiplatelet drugs.
- High-dose saffron supplements should be avoided during pregnancy because of concern about uterine stimulation. Worsening mood, manic symptoms, or persistent erectile dysfunction calls for clinical evaluation rather than reliance on a supplement.
What the research actually shows
Thirty-six married men with stable depressive symptoms on fluoxetine but subjective sexual impairment were randomized to saffron 15 mg twice daily or placebo, and 30 completed four weeks. The time-by-treatment interaction for IIEF total was p=0.009, with erectile function and intercourse satisfaction favoring saffron at p<0.001 and p=0.001. Nine men receiving saffron, 60%, and one receiving placebo, 7%, reached the normal erectile-function threshold. Orgasmic function at p=0.095, overall satisfaction at p=0.334, and sexual desire at p=0.517 were not significant. The 2022 Concerto review of 10 nutraceutical randomized trials concluded that saffron may help but highlighted mixed findings, small samples, depressive status, and the need for larger trials.
Why this is classified as C (42)
The four-week double-blind placebo-controlled trial randomized 36 men, retained 30, and produced consistently positive IIEF-total, erectile-function, intercourse-satisfaction, and normal-function outcomes, so treating it as null or poor-quality evidence would be inappropriate. It remains a single short study with a small sample, subjective IIEF measures across multiple domains, no independent replication in the same male fluoxetine indication, and several nonsignificant domains. Under rule ①, the evidence cannot exceed C and receives a low C with 42 points. Product standardization, gastrointestinal effects, bleeding, and pregnancy precautions remain independent safety issues.
Counterpoint. Sexual dysfunction can reflect depression itself, relationship, vascular or hormonal conditions, or other medicines. If saffron is considered, prescriber-guided dose adjustment, switching antidepressants, and adjunctive options with stronger evidence should be compared at the same time.
Rejudgment record. Cross-check applied — The four-week double-blind placebo-controlled trial with 36 randomized men and 30 completers produced consistently positive IIEF-total, erectile-function, intercourse-satisfaction, and normal-function outcomes, so it was not treated as null or poor-quality evidence. Under rule ①, its single short, small-sample, subjective-scale, multiple-domain design and lack of independent replication in the same male fluoxetine-induced indication limit it to a low C with 42 points
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Improved fluoxetine-induced erectile dysfunction in men | C | The four-week placebo-controlled result was positive, but it is one small study with 36 randomized and 30 completers and no independent replication. |
| Improved IIEF total score in men taking fluoxetine | C | The time-by-treatment interaction was significant, but the small sample, four-week follow-up, and multiple domains limit confirmation. |
| Improved intercourse satisfaction in men taking fluoxetine | C | Intercourse satisfaction was positive, but desire, orgasm, and overall satisfaction were not significant, and no replication exists. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Modabbernia A et al. 2012 | Four-week randomized double-blind placebo-controlled trial | 30 | Indexed as non-United States government research support; detailed funding was not stated in the abstract | IIEF total and erectile function, intercourse satisfaction, orgasmic function, overall satisfaction, and desire domains | Erectile function, intercourse satisfaction, total score, and achievement of normal erectile function favored saffron, while orgasm, overall satisfaction, and desire were not significant. | Pivotal direct positive randomized trial; small, short, and not independently replicated |
| Concerto C et al. 2022 | Systematic review of nutraceutical randomized trials for antidepressant-induced sexual dysfunction | 6 | Authors reported no conflicts; no specific commercial funding was reported in the article | Validated scales and sexual-function domains in antidepressant-induced dysfunction | The review concluded that saffron may help, but findings remained mixed and larger samples with better control of confounding were needed. | Scope-of-evidence review; not a new independent male replication |
Receipt — 2 References
All 2 cited sources were verified for existence at the original page (as of 2026-07-22).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-22 · Corrections: none
Cite this verdict
[Chamgap] Saffron extract x improved fluoxetine-induced erectile dysfunction in men — Evidence Grade C·42. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/mens/saffron-extract-fluoxetine-induced-erectile-dysfunction-men/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.